-
Mashup Score: 3Tech Giants Are Set to Spend $200 Billion This Year Chasing AI - 1 month(s) ago
Three months ago, Wall Street punished the world’s largest technology firms for spending enormous amounts to develop artificial intelligence, only to deliver results that failed to justify the costs.
Source: www.bnnbloomberg.caCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Australia’s success in virtually eliminating mpox within six months of an outbreak in 2022 is now being overshadowed by a sudden and alarming resurgence, highlighting the challenges ahead as the world braces for a potentially more dangerous strain.
Source: www.bnnbloomberg.caCategories: General Medicine News, Infectious DiseaseTweet-
“In a dramatic turn, the country saw 179 cases in August alone, more than in the two previous years combined. Nearly 400 have been reported so far in 2024.” https://t.co/mUPO2Gy52N
-
-
Mashup Score: 1
South Africa may have finally turned the corner in fighting the world’s biggest HIV epidemic as prevalence among pregnant people dropped to the lowest in two decades.
Source: www.bnnbloomberg.caCategories: General Medicine News, Infectious DiseaseTweet-
#HIV prevalence among pregnant women in #SouthAfrica 🇿🇦 is at its lowest since 2022. Learn more in @BNNBloomberg. https://t.co/P9xGded9BO
-
-
Mashup Score: 21
South Africa may have finally turned the corner in fighting the world’s biggest HIV epidemic as prevalence among pregnant people dropped to the lowest in two decades.
Source: www.bnnbloomberg.caCategories: General Medicine News, Infectious DiseaseTweet-
#HIV prevalence among pregnant women in #SouthAfrica 🇿🇦 is at its lowest since 2022. Learn more in @BNNBloomberg. https://t.co/P9xGded9BO
-
-
Mashup Score: 17Merck Is in Advanced Talks to Buy Cancer Drugmaker Harpoon Therapeutics - BNN Bloomberg - 11 month(s) ago
Merck & Co. is in advanced talks to acquire cancer drugmaker Harpoon Therapeutics Inc. for around $700 million, people familiar with the matter said.
Source: www.bnnbloomberg.caCategories: General Medicine News, Hem/OncsTweet-
Merck to acquire Harpoon Therapeutics and their TriTAC platform which includes HPN328, their DLL3 T-cell engager. https://t.co/13EF6ApzPV
-
-
Mashup Score: 5
Bayer AG’s Monsanto unit was ordered by a Missouri jury to pay more than $1.5 billion to three former users of its Roundup weedkiller who blamed their cancers on the controversial product.
Source: www.bnnbloomberg.caCategories: General Medicine News, Partners & KOLsTweet-
A verdict against #Monsanto and their herbicide #Roundup linked to #NHL. You can learn more about all this, the background, and how it all started in my true-story book #ToxicExposure available everywhere. Check it out on @amazon @JHUPress & elsewhere. https://t.co/CvhFiVok77
-
-
Mashup Score: 1
The Australian scientist sees his illness not as a death sentence, but an opportunity to transform treatment for a stubbornly intractable form of cancer.
Source: www.bnnbloomberg.caCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In the search for better glioblastoma treatment, brain cancer researchers face many challenges. “But if we don’t push it, those patients are not going to get better,” says our Dr. Hussein Tawbi. https://t.co/8gwVADplRZ @Bloomberg @HTawbi_MD #glioblastoma #EndCancer
-
Tech Giants Are Set to Spend $200 Billion This Year Chasing AI! https://t.co/PSqYodfcUZ